hydralazine has been researched along with mopidralazine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Criscuolo, D; Indiveri, F; Pende, D; Poggi, A; Scudeletti, M | 1 |
Baldoli, E; Di Francesco, GF; Glässer, A; Marchetti, G | 1 |
Baldoli, E; Bellasio, E; Campi, A; Di Mola, N | 1 |
3 other study(ies) available for hydralazine and mopidralazine
Article | Year |
---|---|
The effects of a new phthalazine derivative (MDL 899) on human lymphocyte functions.
Topics: Antibodies, Monoclonal; Histocompatibility Antigens Class II; HLA-DR Antigens; Humans; Hydralazine; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Lymphocytes; Mitogens; Pyridazines; Rosette Formation | 1986 |
Hemodynamic profile of N-(2,5-dimethyl-1H-pyrrol-1-yl)6-(4-morpholinyl)-3-pyridazinamine hydrochloride in conscious dogs.
Topics: Animals; Blood Pressure; Cardiac Output; Coronary Circulation; Dogs; Heart Rate; Hemodynamics; Hydralazine; Male; Myocardial Contraction; Pulmonary Circulation; Pyridazines; Renal Circulation; Stroke Volume; Vascular Resistance; Vasodilator Agents | 1986 |
Antihypertensives. N-1H-Pyrrol-1-yl-3-pyridazinamines.
Topics: Animals; Antihypertensive Agents; Dogs; Heart Rate; Hydralazine; Hypertension; Hypertension, Renal; Mutagenicity Tests; Pyridazines; Pyrroles; Rats | 1984 |